Syam Palakurthy, CEO & Founder
SamaCare is an enterprise SaaS platform that improves patient access to complex specialty medications, with a focus on automating prior authorizations and benefits verifications.
“The support of Questa Capital and our current investors will help us accelerate much-needed change to a cumbersome system.”
Syam Palakurthy
Founder & CEO
Their story
Prior authorization remains one of the biggest barriers to patient access for high-cost specialty medications. The process is complex, manual, and often leads to treatment delays that impact patient outcomes.
Recognizing this challenge, Syam Palakurthy founded SamaCare in 2018 to simplify and streamline prior authorization for specialty practices. With a background in management consulting and healthcare technology, he saw firsthand how administrative hurdles delayed or prevented patients from receiving essential treatments.
SamaCare’s platform automates prior authorization workflows, reducing administrative burdens and improving approval timelines. By eliminating inefficiencies, the company enhances patient access, streamlines provider operations, and supports manufacturer-driven therapy adoption — ensuring that life-changing treatments reach patients faster.
.avif)
Our partnership
As a result of a proactive thesis in specialty pharmaceutical access and hub assisted services, we identified SamaCare as an emerging player with a strong mission to remove administrative barriers for high-cost drugs for patients who need them. From our first conversations, we were impressed by Syam’s deep understanding of the problem, his clear vision for the company, and the team’s ability to turn prior authorization from a manual burden into an efficient, technology-driven process.
We partnered with SamaCare in early 2024 to support its next phase of growth. Since investing, we have worked closely with the company to expand into new therapeutic areas, enhance product capabilities, strengthen their team, and further improve patient access.
The team involved
“Our team’s extensive experience with investments within the specialty pharmaceutical ecosystem has deepened our appreciation for SamaCare’s pivotal role in helping patients start and stay on their treatment regimens, ultimately leading to better outcomes.”
Dr. Aabed Meer, Partner
Questa Capital
.avif)